If you typed ZEED Pharmaceutical Solutions into a search box, you are probably building a CRO shortlist. This article uses only what ZEED Pharmaceutical Solutions publishes (zeed.com.mx) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.
What ZEED Pharmaceutical Solutions publishes
ZEED Pharmaceutical Solutions is a Mexico City firm that plans and follows clinical research for new pharmaceutical products and medical devices. It emphasizes NOM-012, COFEPRIS and independent monitoring, and advertises Phase I PK, bioavailability and bioequivalence studies.
ZEED Pharmaceutical Solutions vs bioaccess®
| Dimension | ZEED Pharmaceutical Solutions | bioaccess® |
|---|---|---|
| Core focus | Mexico BE / PK and independent monitoring | First-in-human and early feasibility studies for medical devices |
| Geography | See provider site | Latin America, since 2010 |
| Device FIH track record | No named device first-in-human study found on the public pages reviewed | Published case studies on bioaccessla.com |
| After the trial | See provider site | Live multi-country sanitary registration and in-country holder service |
Where each one fits
If the need is independent monitoring or a bioequivalence package for COFEPRIS, ZEED fits.
If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO on your list, including ZEED Pharmaceutical Solutions, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.
Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.
Ready to compare a proposal? Request a first-in-human study proposal.
Competitor facts from the ZEED Pharmaceutical Solutions public pages linked above and public announcements, reviewed for bioaccess® competitive research (Aug–Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.
Leave a Reply